NDC 0008-2001-01 - Protonix I.V.
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0008-2001
- Requested NDC
- 0008-2001-01
- Package NDCs from labels
- 0008-2001-01, 0008-2001-25, 0008-2001-10
- Manufacturer
- Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Takeda GmbH | Pharmacia & Upjohn Company LLC
- Effective date
- 2022-05-10
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| PANTOPRAZOLE SODIUM | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Takeda GmbH | Pharmacia & Upjohn Company LLC | 2022-05-10 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0008-2001-01 | EA - Each | 0008-2001 | ad389b07-7de3-422f-b0ff-7201c7e3a0c0 | 1 | 2014-04-03 |
| 0008-2001-10 | EA - Each | 0008-2001 | bda3bf5d-8674-4692-b11d-f8e080e04d1c | 1 | 2014-04-03 |
| 0008-2001-25 | EA - Each | 0008-2001 | 5d5925d0-ec2a-4b9a-aa1c-c0909dde694b | 1 | 2014-04-03 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| PANTOPRAZOLE SODIUM | ACTIVE INGREDIENT | 6871619Q5X | PROTONIX I.V. (PANTOPRAZOLE SODIUM) INJECTION, POWDER, FOR SOLUTION [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.] | 4 | |
| PANTOPRAZOLE | ACTIVE MOIETY | D8TST4O562 | PROTONIX I.V. (PANTOPRAZOLE SODIUM) INJECTION, POWDER, FOR SOLUTION [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.] | 4 | |
| EDETATE DISODIUM | INACTIVE INGREDIENT | 7FLD91C86K | PROTONIX I.V. (PANTOPRAZOLE SODIUM) INJECTION, POWDER, FOR SOLUTION [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.] | 4 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | PROTONIX I.V. (PANTOPRAZOLE SODIUM) INJECTION, POWDER, FOR SOLUTION [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.] | 4 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Pantoprazole Sodium | PANTOPRAZOLE SODIUM | NuCare Pharmaceuticals, Inc. | 4fbec80c-b38d-122c-e054-00144ff88e88 | 2024-07-15 | Warnings, Adverse reactions | 6871619Q5X |
| PANTOPRAZOLE SODIUM | PANTOPRAZOLE | Proficient Rx LP | 50a278de-bd16-417c-a741-81bfe0d745f2 | 2024-07-01 | Warnings, Adverse reactions | 6871619Q5X |
| Pantoprazole Sodium DR | PANTOPRAZOLE SODIUM | Advanced Rx of Tennessee, LLC | 1c46140c-2399-5ca3-e063-6394a90af33b | 2024-06-27 | Warnings, Adverse reactions | 6871619Q5X |
| Pantoprazole Sodium | PANTOPRAZOLE SODIUM | NuCare Pharmaceuticals,Inc. | 924a80b9-de48-90c0-e053-2995a90a00e1 | 2024-06-19 | Warnings, Adverse reactions | 6871619Q5X |
| PANTOPRAZOLE SODIUM | PANTOPRAZOLE | NuCare Pharmaceuticals,Inc. | 8748a588-a1e5-9dfc-e053-2a95a90a846c | 2024-06-14 | Boxed warning, Warnings, Adverse reactions | 6871619Q5X |
| Pantoprazole Sodium | PANTOPRAZOLE SODIUM | NuCare Pharmaceuticals,Inc. | 88f408cf-1b3e-4d7a-e053-2a95a90a369f | 2024-06-14 | Warnings, Adverse reactions | 6871619Q5X |
| Pantoprazole Sodium | PANTOPRAZOLE SODIUM | NCS HealthCare of KY, LLC dba Vangard Labs | 1680b4ed-d5b0-4fd9-b1d1-04df6a2138be | 2024-06-12 | Warnings, Adverse reactions | 6871619Q5X |
| Pantoprazole Sodium | PANTOPRAZOLE SODIUM | Bryant Ranch Prepack | 7d51104d-b135-421f-8425-03b5772e7103 | 2024-05-20 | Warnings, Adverse reactions | 6871619Q5X |
| Pantoprazole Sodium | PANTOPRAZOLE SODIUM | Asclemed USA, Inc. | 138b30cb-6b28-450e-9e7a-42576cc76545 | 2024-05-01 | Warnings, Adverse reactions | 6871619Q5X |
| Pantoprazole Sodium | PANTOPRAZOLE SODIUM | A-S Medication Solutions | 485212d4-caee-4a55-8299-87a28d6bd8f0 | 2024-04-29 | Warnings, Adverse reactions | 6871619Q5X |
| PANTOPRAZOLE SODIUM | PANTOPRAZOLE | A-S Medication Solutions | 39ba58cc-e4ef-4b82-a0f3-9583fa123a38 | 2024-04-25 | Warnings, Adverse reactions | 6871619Q5X |
| PANTOPRAZOLE SODIUM | PANTOPRAZOLE | A-S Medication Solutions | 3a8fa326-ad75-4b6d-8832-0a2357eeca2f | 2024-04-25 | Warnings, Adverse reactions | 6871619Q5X |
| Pantoprazole Sodium | PANTOPRAZOLE SODIUM | Bryant Ranch Prepack | 3e5421ef-0875-4a04-b17d-95cca0052c83 | 2024-04-04 | Warnings, Adverse reactions | 6871619Q5X |
| PANTOPRAZOLE SODIUM | PANTOPRAZOLE | Bryant Ranch Prepack | 617bb464-5357-472f-8e9d-61aae5b2ebef | 2024-04-03 | Warnings, Adverse reactions | 6871619Q5X |
| Pantoprazole Sodium | PANTOPRAZOLE SODIUM | Golden State Medical Supply, Inc. | d6aae78e-308b-7072-e053-2a95a90aaa10 | 2024-03-29 | Warnings, Adverse reactions | 6871619Q5X |
| PANTOPRAZOLE SODIUM | PANTOPRAZOLE | Asclemed USA, Inc. | 3540d01c-da0e-477e-9e90-994b96deb1d6 | 2024-03-13 | Warnings, Adverse reactions | 6871619Q5X |
| PANTOPRAZOLE SODIUM | PANTOPRAZOLE | Asclemed USA, Inc. | ff15c4f1-8869-4422-9631-dc488e09e583 | 2024-02-14 | Warnings, Adverse reactions | 6871619Q5X |
| PANTOPRAZOLE SODIUM | PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE | Baxter Healthcare Company | a476e063-9450-4793-9a22-16b0a0a61cd0 | 2024-02-14 | Warnings, Adverse reactions | 6871619Q5X |
| Pantoprazole | PANTOPRAZOLE | NorthStar RxLLC | 82f0103a-2b97-d210-6d7d-c627d60ad694 | 2023-12-19 | Warnings, Adverse reactions | 6871619Q5X |
| Pantoprazole Sodium | PANTOPRAZOLE SODIUM | A-S Medication Solutions | 517d6b02-0e68-4d6b-98b3-eac0be457e6b | 2023-12-16 | Warnings, Adverse reactions | 6871619Q5X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.